Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ballarat
Clinical trial register · Australia

Clinical Trials in Ballarat, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC3 AbbVie3 Regeneron Pharmaceuticals2 AstraZeneca2 GlaxoSmithKline2
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Ballarat

35 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
AstraZeneca
Phase 3
915
Auchenflower, Ballarat, Clayton, Darlinghurst, Elizabeth Vale, South Brisbane, St Albans
2026-07-16
Recruiting
Atridia Pty Ltd.
Phase 1
15
Bowral, Sydney, Elizabeth Vale, Ballarat, Frankston
2026-05-15
Recruiting
Eikon Therapeutics
Phase 1/2
160
Saint Leonards, Waratah, Ballarat, Camperdown, Frankston
2026-01-20
Recruiting
Boehringer Ingelheim
Phase 3
670
Randwick, Adelaide, Ballarat
2025-11-07
Recruiting
PRIORITY-CONNECT 2 Trial
NCT06976710Colorectal Cancer, Colorectal Neoplasms
Surgical Outcomes Research Centre (SOuRCe)
Not applicable
564
Coffs Harbour, Newcastle, Sydney, Wagga Wagga, Wollongong, Brisbane, Adelaide, Ballarat
2025-10-15
Recruiting
Pfizer
Phase 3
680
Waratah, Westmead, Hobart, Ballarat
2025-09-29
Recruiting
AbbVie
Phase 2
110
Blacktown, Lambton Heights, Brisbane, Chermside, Ballarat, Clayton, Nedlands
2025-05-28
Recruiting
Monash University
Not applicable
100
Ararat, Ballarat, Beaufort, Daylesford, Maryborough, Nhill, Saint Arnaud, Warracknabeal
2025-05-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Townsville, Adelaide, Ballarat, Melbourne, Perth
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Waratah, Southport, Woolloongabba, Ballarat, Nedlands
2024-10-21
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Ballarat, Bendigo, Birtinya, Brisbane, Camperdown, Clayton, Concord, Garran
2024-08-30
Recruiting
National Robotics-Assisted Radical Prostatectomy Database
NCT06279260Database, Prostate Cancer, Robotic-assisted Radical Prostatectomy, Surgical Outcomes
Melbourne Health
Observational
10,000
Ballarat, Geelong, Melbourne
2024-07-01
Recruiting
Daiichi Sankyo
Phase 3
540
Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
2024-05-21
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Recruiting
GlaxoSmithKline
Phase 3
864
Blacktown, Douglas, Herston, Ballarat, Geelong, Melbourne
2024-03-21
Active, closed
AbbVie
Phase 1
152
Camperdown, Ballarat, Fitzroy
2024-03-08
Recruiting
PharmAbcine
Phase 1
67
Benowa, Ballarat, Malvern, Melbourne
2024-01-03
Active, closed
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
NCT05788081Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV
DrugsGolcadomide·Opdivo·Rituximab·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
40
Ballarat, Box Hill, Geelong, Heidelberg, Perth
2023-08-31
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
160
Macquarie Park, Wollongong, Ballarat, Bendigo, Fitzroy, Murdoch
2023-08-08
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Macquarie Park, Wagga Wagga, Wollongong, Ballarat, Bendigo
2023-06-30
Active, closed
AbbVie
Phase 3
520
Westmead, Southport, Ballarat, Clayton, Malvern, Melbourne, Richmond, Subiaco
2023-03-15
Active, closed
Hanmi Pharmaceutical Company Limited
Phase 1
170
Adelaide, Ballarat, Clayton, Frankston
2023-01-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Townsville, Ballarat, Perth
2022-01-14
Active, closed
Olivia Newton-John Cancer Research Institute
Phase 2
15
Ballarat, Box Hill, Heidelberg
2021-08-17
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Adelaide, Ballarat, Chermside, Clayton, Concord, Epping, Garran, Gosford
2021-08-14
Active, closed
HUYABIO International, LLC.
Phase 3
450
Wahroonga, Buderim, South Brisbane, Ballarat, Shepparton, Brisbane, Liverpool, Nedlands
2021-08-12
Active, closed
Incyte Corporation
Phase 3
899
Adelaide, Ballarat, Birtinya, Brisbane, Canberra, Clayton, Frankston, Geelong
2021-05-11
Active, closed
GlaxoSmithKline
Phase 2/3
758
South Brisbane, Ashford, Hobart, Ballarat, Melbourne, Mount Waverley
2020-12-08
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ballarat, Bedford Park, Clayton, Garran, Hyde Park, Port Macquarie, Wollongong, Woolloongabba
2020-12-02
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
AstraZeneca
Phase 3
818
Adelaide, Ballarat, Birtinya, Box Hill, Concord, Kurralta Park, North Sydney, Orange
2020-04-16
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Ballarat, Clayton
2019-03-22
Active, closed
Dr. Eliza Hawkes
Phase 1
39
Ballarat, Box Hill, Clayton, Heidelberg, Melbourne
2017-09-07
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Kogarah, Sydney, Woolloongabba, Bedford Park, Ballarat, Box Hill, Clayton, Fitzroy
2017-05-22
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Albury, Tweed Heads, Wahroonga, Ashford, Ballarat, East Bentleigh, Malvern, Parkville
2016-12-22
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/ballarat

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Ballarat.

How many clinical trials are recruiting in Ballarat?

16 of the 35 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ballarat), 35 studies
PhaseStudiesRecruitingShare
Phase 316745.7%
Phase 15214.3%
Phase 2/35214.3%
Phase 24111.4%
Not applicable225.7%
Observational112.9%
Phase 1/2112.9%
Phase 4102.9%

Most active sponsors

Lead sponsors with the most studies (Ballarat)
Lead sponsorStudiesRecruiting
AbbVie31
Merck Sharp & Dohme LLC33
AstraZeneca21
GlaxoSmithKline21
Olivia Newton-John Cancer Research Institute20
Regeneron Pharmaceuticals20
Alpine Immune Sciences Inc, A Subsidiary of Vertex10
Astellas Pharma Global Development, Inc.10
Atridia Pty Ltd.11
Boehringer Ingelheim11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.